Designed and led large scale complex transformations and assisted in building Life Science practice, including definition of new go to-market capabilities, management of vendor partnerships that resulted in 10+ leads in 2023, and driving strategy definition for MedTech in 2023 & 2024 and subsequently developing an execution plan and tracking identified KPIs.
• Optimized client's program and portfolio management (PPM) process, including leading 75+ workshops with cross-functional senior leaders globally, with anticipated staffing efficiencies up to 25%, increased business insights for just in time decision making and early risk identification and mitigation
• Led successful response for competitive RFP for radiopharmaceutical client with a value of $7MM+, the largest project for the Life Sciences practice to date, which included management and influence of multiple functions such as Market Research, Technology, Product, and Change Management

Led $3 MM+ program for the disentanglement of R&D Clinical applications from a parent to a child company for a global pharmaceutical client, which included selection of appropriate software solutions and subsequent oversight of 4 vendors and 25+ individuals across NA, Europe, and India and a mix of agile and waterfall approaches to deliver against agreed upon KPIs, timelines, budget, and scope.
• Fostered social engagement within team, including designing and hosIng a virtual town hall in a new, immersive platform across NA and India practice with 50+ individuals attending
• Developed process and materials (e.g., checklist, welcome kit) for new employee on boarding across LS Consulting Practice
• Co-Led a leadership pillar within Cognizant Women's Empowerment program, including promoting membership participation in HBA and designing and facilitating leadership development webinars, with first webinar attendance of 55 individuals

Led $1MM+ regulatory and compliance projects with oversight of up to six staff, to assist clients in transforming their business strategies, while improving operations and performance. Additionally, managed client relationships, including C-Suite and senior level executives and contributed to business development via drafting of sell sheets used to generate new projects.
• Led in-depth Gap Assessments within Compliance risk management domains (e.g., Sales, Market Access, Managed Care, Medical, and PaRent Services) based on business user needs and compliance guidance and regulations (e.g., AdvaMed, PhRMA Code, DOJ), and supported design and implementation of assessment remediations, including change management plans (e.g., stakeholder analysis, communication strategy) and execution

Managed project work streams across clients within Market Access and Finance that included developing financial model for product launch, government payer contracting, contracting strategies, and assessing / remediating government pricing methodologies to recognize thousands of dollars of savings for clients and ensure compliance with applicable regulations.
• Reviewed and drafted contracting strategies between manufacturers, Group Purchasing Organizations, Wholesalers, Retail Pharmacies, Pharmacy Benefit Managers and Integrated Delivery Networks
• Performed valuation assessments of service fees using excel based models
• Developed corporate governance documents, including policies and standard operating procedures

Joined MedLabs upon college graduation and promoted three times in three years to Manager, Technical Operations.
- Assisted in sales strategy and implementation strategy development and implementation for molecular diagnostics menu based on primary research via physician feedback, market research, and financial analysis
- Optimized revenue via:
* Discovering a flaw in the billing system which illuminated over $5 million in billable funds and brought in over $1 million in revenue
* Analyzing testing volume, reimbursement, reagent/supply inventory to maintain efficacy
* Implementing improved batch running schedules for multiple assays which have saved over $30,000
* Increasing revenue by over 50% on certain assays by renegotiating price due to insufficient reimbursement

- Instrumental in founding of a specialized laboratory focusing on cytology, molecular, and genetic testing
- Developed, and implemented Policies and Standard Operating Procedures (SOPs) in accordance to federal and state laws around Quality Control, Quality Assurance, proper handling of hazardous material, and guidelines for medical diagnostic laboratories. Specifically, the documentation adhered to 42 CFR 493, CLIA guidelines, and multiple state guidelines for medical diagnostic laboratories
- Facilitated federal, state, and non profit regulatory agency audit preparation and performed remediation activities for any deficiencies found during multiple audits by the aforementioned entities. Initial inspection resulted in 0 deviations
- Developed a preliminary validation plan for a Lab Developed Test (LDT) following CLIA and 21 CFR Part 807 guidelines